marketwatch: "new migraine drugs have promise -- and a ,500 price tag.".kennebec journal and morning sentinel.

.mark dallas: good guy with a gun who stopped alleged school shooter.
  • eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
  • .